Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sonia T. Wennier"'
Autor:
José Medina-Echeverz, Maria Hinterberger, Marco Testori, Marlene Geiger, Raphael Giessel, Barbara Bathke, Ronny Kassub, Fabienne Gräbnitz, Giovanna Fiore, Sonia T. Wennier, Paul Chaplin, Mark Suter, Hubertus Hochrein, Henning Lauterbach
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-12 (2019)
CD40 agonists have been investigated as a strategy to awaken the immune system against cancers. Here, the authors use a virus encoding CD40L and tumour-associated antigens to enhance innate and adaptive immunity that together with tumour targeting an
Externí odkaz:
https://doaj.org/article/d593337aeba54d49978178381a7a20e5
Autor:
Sonia T Wennier, Kay Brinkmann, Charlotte Steinhäußer, Nicole Mayländer, Claudia Mnich, Ursula Wielert, Ulrike Dirmeier, Jürgen Hausmann, Paul Chaplin, Robin Steigerwald
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e73511 (2013)
Modified vaccinia virus Ankara (MVA) has been shown to be suitable for the generation of experimental vaccines against cancer and infectious diseases, eliciting strong humoral and cellular immune responses. In viral vectored vaccines, strong recombin
Externí odkaz:
https://doaj.org/article/cf95b989bf854404a65a1147389663d5
Autor:
Giovanna Fiore, M. Geiger, Paul Chaplin, Barbara Bathke, F Gräbnitz, Henning Lauterbach, Hubertus Hochrein, R. Kassub, José Medina-Echeverz, Raphael Giessel, Mark Suter, Sonia T. Wennier, M. Testori, Maria Hinterberger
Publikováno v:
E-Poster Presentations.
Background Virus-based vaccines and appropriate costimulation potently enhance antigen-specific T cell immunity against cancer. In the present study, we exploit both innate and adaptive immune responses triggered by a novel recombinant modified vacci
Autor:
Fabienne Gräbnitz, Ronny Kassub, Barbara Bathke, Sonia T. Wennier, Paul Chaplin, Jose Medina-Echeverz, Marco Testori, Raphael Giessel, Marlene Geiger, Hubertus Hochrein, Henning Lauterbach, Mark Suter, Maria Hinterberger, Giovanna Fiore
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-12 (2019)
Nature Communications
Nature Communications
Virus-based vaccines and appropriate costimulation potently enhance antigen-specific T cell immunity against cancer. Here we report the use of recombinant modified vaccinia virus Ankara (rMVA) encoding costimulatory CD40L against solid tumors. Therap
Autor:
Henning Lauterbach, Hubertus Hochrein, José Medina-Echeverz, Ignacio Melero, Maria Hinterberger, Paul Chaplin, Raphael Giessel, Fabienne Graebnitz, Pedro Berraondo, Giovanna Fiore, Sonia T. Wennier, Barbara Bathke, Mark Suter
Publikováno v:
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 2 (2021)
instname
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 2 (2021)
BackgroundHuman cancers are extraordinarily heterogeneous in terms of tumor antigen expression, immune infiltration and composition. A common feature, however, is the host′s inability to mount potent immune responses that prevent tumor growth effec
Autor:
Sonia T. Wennier, Emily A. Travanty, Megan W. Howard, Kathryn V. Holmes, Scott A. Jeffers, Max Smith, Larissa B. Thackray
Publikováno v:
Journal of Virology
The severe acute respiratory syndrome coronavirus (SARS-CoV) spike glycoprotein (S) is a class I viral fusion protein that binds to its receptor glycoprotein, human angiotensin converting enzyme 2 (hACE2), and mediates virus entry and cell-cell fusio
Autor:
Robin Steigerwald, Nicole Mayländer, Paul Chaplin, Ursula Wielert, Jürgen Hausmann, Sonia T. Wennier, Ulrike Dirmeier, Claudia Mnich, Charlotte Steinhäußer, Kay Brinkmann
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e73511 (2013)
PLoS ONE
PLoS ONE
Modified vaccinia virus Ankara (MVA) has been shown to be suitable for the generation of experimental vaccines against cancer and infectious diseases, eliciting strong humoral and cellular immune responses. In viral vectored vaccines, strong recombin